These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 17981817)

  • 1. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
    Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
    van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
    van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
    J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP.
    Anselmo AP; Cartoni C; Bellantuono P; Maurizi-Enrici R; Aboulkair N; Ermini M
    Haematologica; 1990; 75(2):155-8. PubMed ID: 1694156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
    Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
    Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
    Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
    Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
    van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
    Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
    Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    van den Berg H; Furstner F; van den Bos C; Behrendt H
    Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    Viviani S; Santoro A; Ragni G; Bonfante V; Bestetti O; Bonadonna G
    Eur J Cancer Clin Oncol; 1985 May; 21(5):601-5. PubMed ID: 2408897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
    Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with the gonadotropin-releasinghormone agonist buserelin to protect spermatogenesis against cytotoxic treatment in young men.
    Krause W; Pflüger KH
    Andrologia; 1989; 21(3):265-70. PubMed ID: 2476046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
    Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.